Aflac Incorporated is a top provider of supplemental health and life insurance, with a market cap of $59.5 billion. Despite lagging behind the market, the stock is up 6.5% YTD. In Q4 2025, total revenue declined 9.3% to $4.9 billion, with adjusted earnings down 5.4% to $818 million.

Analysts predict AFL’s EPS to decline 1.7% to $7.36 for the current fiscal year. The consensus rating from 16 analysts is “Hold.” Barclays lowered its price target on Aflac to $101, citing cautious optimism on life insurers due to strong capital positions and industry consolidation.

The configuration of AFL’s stock has remained consistent over the past three months. On Jan. 8, Barclays lowered its price target on Aflac to $101 from $104, maintaining an “Equal-Weight” rating. The firm cited ongoing headwinds like spread compression and rising technology spending in the industry.

Read more at Yahoo Finance: Is Wall Street Bullish or Bearish on Aflac Stock?